{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"81.0","upperLimit":"92.0","value":"87.0"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"181"}],"units":"Participants"}],"description":"Proportion of patients event free at 3 years following enrollment. Event-free survival is not a primary outcome measure for Arm 2 patients.","dispersionType":"95% Confidence Interval","groups":[{"description":"Experimental","id":"OG000","title":"Arm 1"}],"paramType":"NUMBER","populationDescription":"181 patients were evaluated for event free survival through 3 years for patients enrolled on Arm 1. Event-free survival is not a primary outcome measure for Arm 2 patients.","reportingStatus":"POSTED","timeFrame":"3 Years after enrollment","title":"Event-Free Survival (EFS)","type":"PRIMARY","unitOfMeasure":"Percent probability"}